Rare diseases
Investigational molecules
Locations
Back to the Netherlands97 clinical trials in Heerlen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
The NetherlandsStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
The NetherlandsStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
The NetherlandsEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
The NetherlandsPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
The NetherlandsPhase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate
The NetherlandsEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
The NetherlandsGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
The NetherlandsStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
The NetherlandsStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsTesting a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer
The NetherlandsA Study of Tulisokibart for Adults with Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on multiple sclerosis and stroke management, including trials evaluating new therapeutic approaches for both relapsing and progressive forms of MS.
Novel therapies being tested include frexalimab and tolebrutinib for multiple sclerosis patients.
Comprehensive studies in cancer treatment, with particular focus on lung cancer, melanoma, and prostate cancer therapies.
Innovative approaches including PSMA-PET/CT imaging and immunotherapy combinations are being evaluated.
Studies addressing cardiovascular diseases and related conditions, including innovative treatments for heart disease and stroke prevention.
Trials include pelacarsen for cardiovascular risk reduction and statin therapy evaluations.
Research into pulmonary conditions, particularly focusing on fibrotic lung diseases and their treatment approaches.
Including trials of inhaled treprostinil and nerandomilast for various forms of lung fibrosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
